Vantage Investment Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Vantage Investment Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$22K	Buy	+200	New	+$20.8K	﹤0.01%	422

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vantage Investment Advisors's PRAH Position: Q3 2018 in Review

Vantage Investment Advisors opened a new position in PRA Health Sciences, Inc. (PRAH) in Q3 2018: 200 shares worth $22K. The stake represents ﹤0.01% of the portfolio and ranks #422 among its holdings.

342 funds tracked by Wall St. Rank hold PRAH as of Q3 2018.

Vantage Investment Advisors held 200 shares of PRA Health Sciences, Inc. worth $22K as of Q3 2018.
PRA Health Sciences, Inc. was a new Vantage Investment Advisors position in Q3 2018.
PRA Health Sciences, Inc. made up ﹤0.01% of Vantage Investment Advisors's portfolio in Q3 2018, its #422 holding.
342 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.